News

Ovarian Cancer Research Alliance Joins with Rivkin Center for Ovarian Cancer Research, Strengthening the Fight Against Ovarian Cancer

January 28, 2025

OCRA to Expand its Research Initiatives by Integrating Rivkin Center’s Legacy Efforts, Effective April 2025 NEW YORK, NY, January 28, 2025 – Ovarian Cancer Research Alliance (OCRA), the world’s largest gynecologic cancer nonprofit, is proud to announce that the Rivkin Center for Ovarian Cancer Research will combine with OCRA, effective April 1, 2025. This historic collaboration … Continued

OCRA News

How OCRA-Funded Research is Harnessing AI and Nanotechnology for Earlier Ovarian Cancer Detection, a Conversation with Clarke’s Closer Look

January 27, 2025

In a new interview with journalist Marcel Clarke for Clarke’s Closer Look, OCRA grantee Dr. Daniel Heller of Memorial Sloan Kettering Cancer Center discusses how his lab is utilizing artificial intelligence (AI) to develop a cutting-edge blood test to detect ovarian cancer at its earliest stages. This OCRA-funded study is in partnership with Microsoft AI … Continued

OCRA News

Advocate’s Corner: January 2025

January 23, 2025

Happy New Year from OCRA’s Policy and Advocacy Team! As we step into a new year, we want to take a moment to thank you for your unwavering support and dedication. Each year brings fresh opportunities to drive meaningful change for the ovarian and gynecologic cancer community, and we couldn’t do it without you. Update … Continued

Advocacy

OCRA Discusses Ovarian Cancer Risk & Prevention with Clarke’s Closer Look

January 22, 2025

In a new interview with journalist Marcel Clarke, OCRA’s Chief Program Officer, Sarah DeFeo, discusses the importance of ovarian cancer risk awareness and prevention. The interview appears on Clarke’s Closer Look.

OCRA News

OCRA Surpasses Year-End Fundraising Goals, Fueling Critical Research and Patient Support Programs

January 15, 2025

[New York, NY – January 15, 2025] – Ovarian Cancer Research Alliance (OCRA) proudly announces the extraordinary success of its 2024 year-end fundraising campaign, surpassing its $2 million goal and marking a transformative milestone in its mission to eradicate ovarian and related gynecologic cancers. Fueled by the generosity and unwavering support of donors, this achievement … Continued

OCRA News

OCRA-Funded Research Identifies Promising Therapeutic Strategy to Improve Immune Response Against Ovarian Cancer

January 14, 2025

A study recently published in Science Advances and supported in part by Ovarian Cancer Research Alliance has advanced scientists’ understanding of how to potentially overcome immune evasion in ovarian cancer. The research team involved current and former Memorial Sloan Kettering Cancer Center researchers, including OCRA grantee Melica Brodeur MD, MSc, now at McGill University, who … Continued

Research

A Celebration of Community to Commence the New Year

January 9, 2025

More than 60 gynecologic cancer patients and survivors came together at the end of December for holiday merriment, celebrating of participants’ triumphs, and embracing the new year during a special session of Ovarian Cancer Research Alliance’s online expressive arts series facilitated by our oncology social workers.  Ahead of this Express Yourself session, which centered on … Continued

Community

The Overview: December 2024

December 22, 2024

A Year of Progress: Advances in the Fight Against Ovarian and All Gynecologic Cancers This year, your support enabled Ovarian Cancer Research Alliance (OCRA) to make incredible strides in research, advocacy, and patient support for those facing ovarian and all gynecologic cancers. With your help, we expanded our support programs, fostered critical collaborations, and continued … Continued

OCRA News

Advocate’s Corner: December 2024

December 22, 2024

As we close out 2024, we at OCRA are reflecting on a year of powerful advocacy and immense gratitude. Your passion and commitment to raising awareness, driving policy change, and pushing for progress for the ovarian and gynecologic cancer community have left a mark that will be felt for years to come.  Here are some … Continued

Advocacy

BBC Features OCRA-Funded Research in AI Breakthroughs Series

December 20, 2024

OCRA-funded research using artificial intelligence (AI) for ovarian cancer early detection was highlighted in the BBC’s six-part series on how AI is transforming medicine. Dr. Daniel Heller, an OCRA-funded researcher at Memorial Sloan Kettering Cancer Center, shared how his team is using AI and nanotechnology to develop a cutting-edge blood test for early ovarian cancer … Continued

OCRA News

OCRA Statement Urging Passage of Bipartisan Year-End Health Care Package

December 18, 2024

“To improve patient outcomes – and quality of life – we must minimize roadblocks for access to cancer screenings that could change the course of a diagnosis. The time is now. We are urging Congressional action this week to enact this legislation into law.” The Ovarian Cancer Research Alliance today released the following statement regarding … Continued

Advocacy

IQVIA Institute for Human Data Science Shares Important Insights from Panel Discussion on Changing Oncology Landscape

December 18, 2024

IQVIA Institute for Human Data Science recently shared key takeaways from its panel discussion on global oncology trends that included OCRA President & CEO Audra Moran, MPN Research Foundation CEO Kapila Viges, and IQVIA Oncology Center of Excellence Vice President Jeff Hodge. The discussion, which was moderated by IQVIA Institute for Human Data Science Executive … Continued

OCRA News